| Clinical data | |
|---|---|
| Other names | Enallylpropymal |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.015.876 |
| Chemical and physical data | |
| Formula | C11H16N2O3 |
| Molar mass | 224.260 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
| (verify) | |
Enallylpropymal (Narconumal) is abarbiturate derivative developed by Hoffman la Roche in the 1930s.[1] It hassedative andhypnotic effects and is considered to have a moderate abuse potential.[2]